News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
192,982 Results
Type
Article (8555)
Company Profile (10)
Press Release (184414)
Multimedia
Podcasts (13)
Webinars (4)
Section
Business (58024)
Career Advice (530)
Deals (10390)
Drug Delivery (26)
Drug Development (24595)
Employer Resources (31)
FDA (4285)
Job Trends (4435)
News (95155)
Policy (7389)
Tag
Academia (493)
Accelerated approval (18)
Adcomms (5)
Allergies (73)
Alliances (7279)
ALS (97)
Alzheimer's disease (592)
Antibody-drug conjugate (ADC) (250)
Approvals (4660)
Artificial intelligence (286)
Autoimmune disease (138)
Automation (23)
Bankruptcy (110)
Best Places to Work (3988)
BIOSECURE Act (3)
Biosimilars (114)
Biotechnology (12)
Bladder cancer (140)
Brain cancer (30)
Breast cancer (412)
Cancer (3189)
Cardiovascular disease (263)
Career advice (437)
Career pathing (3)
CAR-T (148)
CDC (7)
Cell therapy (381)
Cervical cancer (24)
Clinical research (24153)
Collaboration (911)
Company closure (2)
Compensation (580)
Complete response letters (27)
COVID-19 (744)
CRISPR (47)
C-suite (371)
Cystic fibrosis (56)
Data (4400)
Decentralized trials (1)
Depression (65)
Dermatology (39)
Diabetes (266)
Diagnostics (2052)
Digital health (20)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (129)
Drug pricing (53)
Drug shortages (7)
Duchenne muscular dystrophy (120)
Earnings (48709)
Editorial (13)
Employer branding (5)
Employer resources (27)
Events (31650)
Executive appointments (447)
FDA (6152)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (3)
Frontotemporal dementia (18)
Funding (764)
Gene editing (103)
Generative AI (17)
Gene therapy (300)
GLP-1 (478)
Government (1209)
Grass and pollen (5)
Guidances (354)
Healthcare (5317)
HIV (52)
Huntington's disease (16)
IgA nephropathy (47)
Immunology and inflammation (121)
Immuno-oncology (44)
Indications (89)
Infectious disease (914)
Inflammatory bowel disease (104)
Inflation Reduction Act (3)
Influenza (66)
Intellectual property (82)
Interviews (94)
IPO (6705)
IRA (8)
Job creations (715)
Job search strategy (382)
JPM (11)
Kidney cancer (16)
Labor market (33)
Layoffs (171)
Leadership (7)
Legal (1402)
Liver cancer (40)
Longevity (6)
Lung cancer (464)
Lymphoma (295)
Machine learning (24)
Management (10)
Manufacturing (319)
MASH (91)
Medical device (3849)
Medtech (3881)
Mergers & acquisitions (4232)
Metabolic disorders (716)
mRNA (44)
Multiple sclerosis (98)
NASH (7)
Neurodegenerative disease (175)
Neuropsychiatric disorders (57)
Neuroscience (1274)
NextGen: Class of 2026 (1414)
Non-profit (1055)
Now hiring (20)
Obesity (341)
Opinion (53)
Ovarian cancer (110)
Pain (105)
Pancreatic cancer (135)
Parkinson's disease (156)
Partnered (6)
Patents (149)
Patient recruitment (277)
Peanut (32)
People (6649)
Pharmaceutical (2)
Pharmacy benefit managers (10)
Phase 1 (6420)
Phase 2 (10163)
Phase 3 (9385)
Pipeline (4834)
Policy (44)
Postmarket research (954)
Preclinical (2150)
Press Release (12)
Prostate cancer (170)
Psychedelics (15)
Radiopharmaceuticals (107)
Rare diseases (481)
Real estate (922)
Recruiting (12)
Regulatory (6916)
Reports (17)
Research institute (474)
Resumes & cover letters (90)
Rett syndrome (30)
RNA editing (3)
RSV (56)
Schizophrenia (88)
Series A (113)
Series B (94)
Service/supplier (1)
Sickle cell disease (62)
Special edition (10)
Spinal muscular atrophy (78)
Sponsored (11)
Startups (603)
Stomach cancer (7)
Supply chain (44)
Tariffs (19)
The Weekly (12)
Vaccines (393)
Venture capital (48)
Weight loss (230)
Women's health (46)
Worklife (7)
Date
Today (4)
Last 7 days (347)
Last 30 days (1214)
Last 365 days (15652)
2026 (4784)
2025 (16153)
2024 (13654)
2023 (12586)
2022 (16376)
2021 (16027)
2020 (14213)
2019 (12463)
2018 (9248)
2017 (8431)
2016 (7674)
2015 (8968)
2014 (6474)
2013 (5020)
2012 (5583)
2011 (6090)
2010 (5121)
Location
Africa (199)
Alabama (20)
Alaska (2)
Arizona (77)
Arkansas (5)
Asia (11659)
Australia (1930)
California (6481)
Canada (1563)
China (619)
Colorado (253)
Connecticut (293)
Delaware (257)
Europe (28329)
Florida (738)
Georgia (196)
Hawaii (3)
Idaho (19)
Illinois (534)
India (36)
Indiana (273)
Iowa (9)
Japan (348)
Kansas (32)
Kentucky (23)
Louisiana (25)
Maine (35)
Maryland (599)
Massachusetts (4751)
Michigan (113)
Minnesota (313)
Mississippi (4)
Missouri (68)
Montana (9)
Nebraska (5)
Nevada (81)
New Hampshire (31)
New Jersey (1813)
New Mexico (8)
New York (1564)
North Carolina (661)
North Dakota (5)
Northern California (3254)
Ohio (175)
Oklahoma (5)
Oregon (9)
Pennsylvania (1062)
Puerto Rico (6)
Rhode Island (14)
South America (295)
South Carolina (14)
Southern California (2479)
Tennessee (90)
Texas (1006)
United States (21803)
Utah (158)
Vermont (1)
Virginia (152)
Washington D.C. (18)
Washington State (477)
West Virginia (2)
Wisconsin (101)
192,982 Results for "7".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
L7 Informatics Announces L7 SYNAPSE™: Advancing Context-Aware AI for Regulated Scientific Execution
April 9, 2026
·
1 min read
Podcast
Trump’s psychedelics push, Lilly’s up to $7B CAR T deal, Replimune’s saga and Denali’s big win
The deals keep rolling in, with Lilly penning a
$7 billion pact
for gene delivery biotech Kelonia Therapeutics and UCB taking over cell therapy-focused
Neurona Therapeutics
; President Trump signed a new
executive order
supporting the development of psychedelic therapies, sparking fanfare and concern alike; and the FDA’s recent Replimune decision has triggered broader debate about the agency’s flexibility.
April 22, 2026
·
1 min read
·
Heather McKenzie
Press Releases
Digital Disruption in Life Sciences: L7 Informatics Says Competitive Advantage Will Come From Governed Execution
L7 Informatics CEO explains why the next wave of life sciences innovation depends on digital unified platforms that orchestrate workflows, contextualize data, and enable AI-actionable operations.
February 12, 2026
·
1 min read
Press Releases
IBA – ACQUISITION OF OWN SHARES - April 7, 2026
April 8, 2026
·
2 min read
Press Releases
Codexis to Report First Quarter 2026 Financial Results on May 7
April 23, 2026
·
1 min read
Press Releases
OmniAb to Report First Quarter 2026 Financial Results on May 7
April 21, 2026
·
1 min read
Press Releases
Collegium to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
·
1 min read
Press Releases
Vericel to Report First-Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
·
1 min read
Press Releases
Ligand to Report First Quarter 2026 Financial Results on May 7, 2026
April 22, 2026
·
1 min read
Press Releases
Novo Nordisk A/S: Wegovy® HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss
March 19, 2026
·
5 min read
1 of 19,299
Next
